Reduction of suicidality in patients with schizophrenia receiving clozapine

Clinical Drug Investigation

Volumn 22, Issue 5, 2002, Pages 341-346

  Reinstein, Michael J ^a   Chasonov, Maxim A ^a   Colombo, Kathleen D ^a   Jones, Lynne E ^a   Sonnenberg, John G ^a  

^a Uptown Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GRANULOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; TREATMENT OUTCOME;

EID: 0036091029     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222050-00008     Document Type: Article

References (28)

1. Clozapine for treatment-resistant schizophrenia
2. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
3. Clinical and biological response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine
4. Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns
5. Effects of clozapine on postiive and negative symptoms in outpatients with schizophrenia
6. Clinical effects of clozapine in chronic schizophrenia: Response to treatment and preditctors of outcome
7. A comparison of clozapine and haloperidol in hospitalised patients with refractory schizophrenia
8. Schizophrenia and schizophrenia-like disorders
9. Epidemiology of schizophrenia: A European perspective
10. How does gender influence age at first hospitalization of schizophrenia
11. Suicide prevention effects associated with clozapine therapy in schizophrenia and schizo-affective disorder
12. Suizid and suizidversuch im verlauf schizophrener erkrankungen
13. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment
14. Evaluation of suicide prevention after attempted suicide
15. Risk for suicide in schizophrenia and other psychotic and non-psychotic disorders
16. Schizophrenics kill themselves too: A review of risk factors for suicide
17. Impact of clozapine on completed suicide
18. Clozapine: An typical antipsychotic agent
19. A report of clozapine-induced agranulocytosis in the United States. Incidence and risk factors
20. Incidence and treatment of side effects with clozapine treatment
21. Who should receive clozapine?
22. Characteristics of outpatient suicides
23. Suicide and schizophrenia: Clozapine and the InterSePT study
24. Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients
25. Mortality in current and former users of clozapine
26. Suicide in schizophrenia: Risk factors and clozapine treatment